Recombinant Botulinum Toxin Type A
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Recombinant Botulinum Toxin Type A, covering 2023-02-24 to 2024-09-04. Get the full timeline:
Most recent: Clinical Trial Update: A Study on the Efficacy and Safety of Repeated Treatments With Recombinant Botulinum Toxin Type A for Injection in the Treatment of Moderate to Severe Glabellar Lines [Phase 3]